These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38190963)

  • 1. Efficacy and safety of lascufloxacin for nursing- and healthcare-associated pneumonia: A single-arm, open-label clinical trial.
    Takazono T; Hosogaya N; Fukushima K; Morio R; Irifune S; Miyamura T; Harada Y; Nagayoshi Y; Kondo A; Mihara T; Fukuda Y; Sasaki E; Sawai T; Imamura Y; Morikawa T; Futsuki Y; Inoue Y; Fukushima K; Suyama N; Tanaka H; Hanaka T; Shimabukuro I; Hata R; Ota K; Morimoto S; Nakada N; Ito Y; Yoshida M; Takeda K; Ide S; Iwanaga N; Nemoto K; Funada M; Izumikawa K; Yatera K; Yanagihara K; Mukae H
    J Infect Chemother; 2024 Jul; 30(7):597-602. PubMed ID: 38190963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of efficacy and safety of lascufloxacin for nursing and healthcare associated pneumonia: single-arm, open-label clinical trial: A study protocol.
    Hosogaya N; Takazono T; Ota K; Kiya R; Shirai Y; Kawasaki R; Yano H; Morimoto S; Nakao R; Kanamaru Y; Yoshino Y; Ishikawa Y; Fukushima C; Yamamoto H; Izumikawa K; Yanagihara K; Mukae H
    Medicine (Baltimore); 2023 Feb; 102(8):e33092. PubMed ID: 36827005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Drip Infusion of Lascufloxacin, a Novel Fluoroquinolone Antibiotic, for Patients with Pneumonia Including Chronic Lung Disease Exacerbations and Lung Abscesses.
    Shimada D; Seki M
    Infect Drug Resist; 2024; 17():911-918. PubMed ID: 38476768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of lascufloxacin in non-elderly healthy men and elderly men.
    Totsuka K; Sesoko S; Fukase H; Ikushima I; Odajima M; Niwayama Y
    J Infect Chemother; 2020 Mar; 26(3):231-239. PubMed ID: 31882385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of sitafloxacin and garenoxacin for the treatment of pneumonia in elderly patients: A randomized, multicenter, open-label trial.
    Miyazaki T; Nakamura S; Hashiguchi K; Kobayashi T; Fukushima K; Fukuda Y; Kondo A; Inoue Y; Koga H; Sasaki E; Nagayoshi Y; Higashiyama Y; Yoshida M; Takazono T; Saijo T; Morinaga Y; Yamamoto K; Imamura Y; Mikushi S; Izumikawa K; Yanagihara K; Kohno S; Mukae H
    J Infect Chemother; 2019 Nov; 25(11):886-893. PubMed ID: 31113725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of moxifloxacin tablet on nursing and health care-associated pneumonia--a prospective study with a simple suspension method].
    Takaku C; Hidaka T
    Jpn J Antibiot; 2013 Apr; 66(2):59-70. PubMed ID: 23951725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three cases of hospitalized Legionella pneumonia patients successfully treated with lascufloxacin.
    Ito A; Kawataki M; Sato R; Nakanishi Y; Ishida T
    J Infect Chemother; 2024 May; ():. PubMed ID: 38815654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of levofloxacin in patients with nursing and healthcare-associated pneumonia].
    Yamasaki K; Yatera K; Kawanami T; Sasahara Y; Hata R; Uchimura K; Tachiwada T; Naito K; Kato K; Takaki T; Shimabukuro I; Shiraishi T; Oda K; Hara K; Chojin Y; Suzuki Y; Akata K; Ogoshi T; Tokuyama S; Inoue N; Noguchi S; Nishida C; Orihashi T; Yoshida Y; Kawanami Y; Taura Y; Ishimoto H; Obata H; Awaya Y; Tsuda T; Yoshii C; Mukae H
    Jpn J Antibiot; 2014 Feb; 67(1):23-32. PubMed ID: 24809206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of urinary tract infection on nursing and healthcare-associated pneumonia.
    Yamazoe M; Tomioka H; Wada T
    J Infect Chemother; 2019 Dec; 25(12):950-954. PubMed ID: 31196770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective multicenter survey for Nursing and Healthcare-associated Pneumonia in Japan.
    Imamura Y; Miyazaki T; Watanabe A; Tsukada H; Nagai H; Hasegawa Y; Tomono K; Ito I; Teramoto S; Ishida T; Kadota JI; Kohno S; Mukae H
    J Infect Chemother; 2022 Aug; 28(8):1125-1130. PubMed ID: 35414437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reevaluation of the Japanese guideline for healthcare-associated pneumonia in a medium-sized community hospital in Japan.
    Oshitani Y; Nagai H; Matsui H; Aoshima M
    J Infect Chemother; 2013 Aug; 19(4):579-87. PubMed ID: 23179959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of nursing and healthcare-associated pneumonia: a Japanese variant of healthcare-associated pneumonia.
    Ishida T; Tachibana H; Ito A; Yoshioka H; Arita M; Hashimoto T
    Intern Med; 2012; 51(18):2537-44. PubMed ID: 22989823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective comparison of nursing- and healthcare-associated pneumonia (NHCAP) with community-acquired pneumonia (CAP).
    Fukuyama H; Yamashiro S; Tamaki H; Kishaba T
    J Infect Chemother; 2013 Aug; 19(4):719-26. PubMed ID: 23354936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in nursing and healthcare-associated pneumonia.
    Yamagata A; Ito A; Nakanishi Y; Ishida T
    J Infect Chemother; 2020 Jun; 26(6):563-569. PubMed ID: 32067902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of moxifloxacin in patients with nursing and healthcare-associated pneumonia].
    Yamasaki K; Yatera K; Kawanaml T; Suzuki Y; Choujin Y; Akata K; Ogoshi T; Tokuyama S; Nagata S; Inoue N; Noguchi S; Nishida C; Orihashi T; Yoshida Y; Kawanami Y; Taura Y; Ishimoto H; Kawajiri T; Obata H; Awaya Y; Yoshii C; Mukae H
    Jpn J Antibiot; 2013 Oct; 66(5):283-92. PubMed ID: 24527518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical profile in elderly patients with nursing and healthcare-associated pneumonia, and those with community-acquired pneumonia.
    Nakagawa N; Saito Y; Sasaki M; Tsuda Y; Mochizuki H; Takahashi H
    Geriatr Gerontol Int; 2014 Apr; 14(2):362-71. PubMed ID: 23829585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is antipseudomonal antibiotic treatment needed for all nursing and healthcare-associated pneumonia patients at risk for antimicrobial resistance?
    Ito A; Ishida T; Tachibana H; Nakanishi Y; Yamazaki A; Washio Y
    J Glob Antimicrob Resist; 2020 Sep; 22():441-447. PubMed ID: 32339851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal effects of lascufloxacin on human gut and salivary microbiota: Analysis using next-generation sequencing method.
    Mukuda K; Inoue R; Takata M; Takazawa K; Noma H; Morishima S; Oda M; Ma'arif AS; Endo Y; Sunada H; Doi A; Matsuda R; Nishikawa Y; Okada K; Kitaura T; Nakamoto M; Yamasaki A; Chikumi H
    J Infect Chemother; 2024 Jul; ():. PubMed ID: 39089446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and the role of atypical pathogens in nursing and healthcare-associated pneumonia (NHCAP): differences between a teaching university hospital and a community hospital.
    Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N
    Intern Med; 2012; 51(6):585-94. PubMed ID: 22449666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.